Literature DB >> 16716969

Contribution of CARD15 variants in determining susceptibility to Crohn's disease in Sweden.

Leif Törkvist1, Colin L Noble, Mikael Lördal, Urban Sjöqvist, Ulrik Lindforss, Elaine R Nimmo, Richard K Russell, Robert Löfberg, Jack Satsangi.   

Abstract

OBJECTIVE: Crohn's disease (CD) is a chronic inflammatory bowel disorder caused by environmental and genetic factors. Mutations in the CARD15 gene have been associated with CD. No previous case-control CARD15 study has been performed in the Swedish population.
MATERIAL AND METHODS: The study comprised of 321 individuals: 178 with CD and 143 healthy controls (HCs), all from Stockholm County. All were genotyped for the three main CD-associated CARD15 variants (R702W, G908R and 1007fs) and phenotypic associations were investigated.
RESULTS: The allele frequencies of the R702W variant (4.5% CD versus 0.7% HC, p=0.008, OR = 6.8) and the G908R variant (2.0% CD versus 0% HC, p=0.045) were more common in CD patients than in controls. No significant difference in1007fs variant allele frequency was found between CD patients and controls (2.0% CD versus 1.7% HC, p = 0.8, OR = 1.1). Carriage of CARD15 variants was more common in the CD patients than in controls (15.2% CD versus 4.2% HC, p = 0.001, OR = 4.1, population attributable risk (PAR) = 11.4%). Genotype-phenotype analysis demonstrated that CARD15 variants were associated with ileal disease (p=0.0006, OR = 9.3, CI = 2.2-34) and protective for colonic CD (p = 0.01, OR = 0.18). An association between CARD15 variants and ileal CD (p=0.004, OR = 6.6) was confirmed by multivariate analyses.
CONCLUSIONS: The CARD15 variants R702W and G908R, but not 1007fs, are associated with susceptibility to CD in Stockholm County. Genotype-phenotype analysis shows an association with ileal CD. The contribution of these CARD15 mutations in Swedish CD patients overall is low in relation to studies elsewhere in Central Europe and North America, but is consistent with emerging data from elsewhere in Scandinavia and in Northern Europe.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16716969     DOI: 10.1080/00365520500395245

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  4 in total

1.  Polymorphisms in NF-κB, PXR, LXR, PPARγ and risk of inflammatory bowel disease.

Authors:  Vibeke Andersen; Jane Christensen; Anja Ernst; Bent A Jacobsen; Anne Tjønneland; Henrik B Krarup; Ulla Vogel
Journal:  World J Gastroenterol       Date:  2011-01-14       Impact factor: 5.742

2.  Analysis of single nucleotide polymorphisms in the region of CLDN2-MORC4 in relation to inflammatory bowel disease.

Authors:  Jan Söderman; Elisabeth Norén; Malin Christiansson; Hanna Bragde; Raphaele Thiébaut; Jean-Pierre Hugot; Curt Tysk; Colm A O'Morain; Miquel Gassull; Yigael Finkel; Jean-Frédéric Colombel; Marc Lémann; Sven Almer
Journal:  World J Gastroenterol       Date:  2013-08-14       Impact factor: 5.742

3.  Assessment of heterogeneity between European Populations: a Baltic and Danish replication case-control study of SNPs from a recent European ulcerative colitis genome wide association study.

Authors:  Vibeke Andersen; Anja Ernst; Jurgita Sventoraityte; Limas Kupcinskas; Bent A Jacobsen; Henrik B Krarup; Ulla Vogel; Laimas Jonaitis; Goda Denapiene; Gediminas Kiudelis; Tobias Balschun; Andre Franke
Journal:  BMC Med Genet       Date:  2011-10-13       Impact factor: 2.103

Review 4.  NOD2 polymorphisms and pulmonary tuberculosis susceptibility: a systematic review and meta-analysis.

Authors:  Chong Wang; Zhong-Liang Chen; Zhi-Fen Pan; Li-Liang Wei; Dan-Dan Xu; Ting-Ting Jiang; Xing Zhang; Ze-Peng Ping; Zhong-Jie Li; Ji-Cheng Li
Journal:  Int J Biol Sci       Date:  2013-12-28       Impact factor: 6.580

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.